SCFFbxo9 and CK2 direct the cellular response to growth factor withdrawal via Tel2/Tti1 degradation and promote survival in multiple myeloma

Autor: Anna-Maria Knorn, Bernhard Kuster, Clemens Reiter, Julia Slotta-Huspenina, Michele Pagano, Florian Bassermann, Bianca-Sabrina Targosz, Christian Peschel, Sonja Schroeder, Christian Langer, Lars Bullinger, Ruth Eichner, Vanesa Fernández-Sáiz, Julia Kurutz, Simone Lemeer
Rok vydání: 2012
Předmět:
Male
Cell Survival
medicine.medical_treatment
Molecular Sequence Data
Plasma Cells
Gene Expression
Kaplan-Meier Estimate
Mechanistic Target of Rapamycin Complex 2
mTORC1
Mechanistic Target of Rapamycin Complex 1
mTORC2
Culture Media
Serum-Free

Disease-Free Survival
Mice
Cell Line
Tumor

medicine
Animals
Humans
Amino Acid Sequence
Phosphorylation
Casein Kinase II
PI3K/AKT/mTOR pathway
Proto-Oncogene Proteins c-ets
biology
Cell growth
F-Box Proteins
TOR Serine-Threonine Kinases
Growth factor
Intracellular Signaling Peptides and Proteins
Proteins
Cell Biology
Peptide Fragments
Cell biology
Ubiquitin ligase
Mice
Inbred C57BL

Case-Control Studies
Multiprotein Complexes
Proteolysis
biology.protein
Intercellular Signaling Peptides and Proteins
biological phenomena
cell phenomena
and immunity

Signal transduction
Carrier Proteins
Multiple Myeloma
Protein Processing
Post-Translational

Protein Binding
Signal Transduction
Zdroj: Nature Cell Biology. 15:72-81
ISSN: 1476-4679
1465-7392
DOI: 10.1038/ncb2651
Popis: The Tel2 (also known as Telo2) and Tti1 proteins control the cellular abundance of mammalian PIKKs and are integral components of mTORC1 and mTORC2. Here we report that Tel2 and Tti1 are targeted for degradation within mTORC1 by the SCFFbxo9 ubiquitin ligase to adjust mTOR signalling to growth factor availability. This process is primed by CK2, which translocates to the cytoplasm to mediate mTORC1-specific phosphorylation of Tel2/Tti1, subsequent to growth factor deprivation. As a consequence, mTORC1 is inactivated to restrain cell growth and protein translation whereas relief of feedback inhibition activates the PI(3)K/TORC2/Akt pathway to sustain survival. Significantly, primary human multiple myelomas exhibit high levels of Fbxo9. In this setting, PI(3)K/TORC2/Akt signalling and survival of multiple myeloma cells is dependent on Fbxo9 expression. Thus, mTORC1-specific degradation of the Tel2 and Tti1 proteins represents a central mTOR regulatory mechanism with implications in multiple myeloma, both in promoting survival and in providing targets for the specific treatment of multiple myeloma with high levels of Fbxo9 expression.
Databáze: OpenAIRE